期刊文献+

氢吗啡酮在全子宫切除术后静脉自控镇痛中的应用效果 被引量:9

Efficacy of hydromorphone in postoperative patient-controlled intravenous analgesia in patients with panhysterectomy
下载PDF
导出
摘要 目的探讨氢吗啡酮在全子宫切除术后静脉自控镇痛中的应用效果。方法选择行全子宫切除术患者60例,按术后静脉镇痛氢吗啡酮的不同剂量随机分为3组。A、B、C组PCIA依次采用氢吗啡酮1、2、3μg/(kg·h)。观察PCIA开始后4、8、12、24、48 h各时点视觉模拟评分(VAS)、Ramsay镇静评分、血流动力学变化、血氧饱和度,不良反应发生率以及PCIA需求按压次数。结果 PCIA开始后4、8、12、24和48 h,B组和C组VAS评分均低于A组(P<0.05),Ramsay镇静评分A组和B组均低于C组(P<0.05)。A组和B组嗜睡发生率低于C组(P<0.05),B组与C组按压次数均少于A组(P<0.05)。结论氢吗啡酮2μg/(kg·h)用于妇科子宫切除术后静脉自控镇痛安全可行,镇痛效果满意,不良反应少。 Objective To explore the efficacy of hydromorphone in postoperative patientcontrolled intravenous analgesia in patients with panhysterectomy. Methods A total of 60 patients with panhysterectomy were selected and randomly divided into three groups according to dosage of hydromorphone. Group A,group B and group C were given hydromorphone 1,2 and 3 μg /( kg·h)respectively. VAS score,Ramsay sedation score,hemodynamics,oxygen saturation,the incidence rate of adverse reactions and PCIA pressing times were observed at the time points of 4,8,12,24,48 hours after start of PCIA. Results At the time points of 4,8,12,24,48 hours after start of PCIA,the VAS score in the group B and group C was significantly lower than that in the group A( P〈0. 05),and the Ramsay sedation score in the group A and the group B was significantly lower than that in the group C( P〈0. 05). The incidence rate of somnolence in the group A and the group B was significantly lower than that in the group C( P〈0. 05),and PCIA pressing times in the group B and the group C were significantly less than the group A( P〈0. 05). Conclusion Hydromorphone2 μg /( kg·h) for patient-controlled intravenous analgesia after hysterectomy is feasible and safe,the analgesia efficacy is good and adverse reactions are less.
出处 《实用临床医药杂志》 CAS 2016年第3期66-68,共3页 Journal of Clinical Medicine in Practice
关键词 氢吗啡酮 静脉自控镇痛 全子宫切除术 hydromorphone patient-controlled intravenous analgesia panhysterectomy
  • 相关文献

参考文献8

  • 1薛照静,黄宇光,赵晶,虞雪融.慢性术后疼痛研究进展[J].中国疼痛医学杂志,2013,19(11):685-689. 被引量:29
  • 2李燕摘,宏景.评估疼痛的最佳方法[J].国际护理学杂志,1998,17(3):126.
  • 3Ramsay M A,Savege T M,Simpson B R,et al.Controlled sedation with alphaxalone-alphadolone[J].Br Med J,1974,2(5920):656.
  • 4崔旭,唐晨,赵晓艳.硬膜外吗啡复合静脉镇痛用于剖宫产术后镇痛的临床观察[J].中国医刊,2013,48(11):38-39. 被引量:5
  • 5Mori T,Shibasaki Y,Matsumoto K,et al.Mechanisms that underlieμ-opioid receptor agonist-induced constipation:differential involvement ofμ-opioid receptor sites and responsible regions[J].J Pharmacol Exp Ther,2013,347(1):91.
  • 6刘汝,胡啸玲,易汉,冯娟,文建.盐酸氢吗啡酮的临床研究进展[J].中国处方药,2014,12(3):119-121. 被引量:57
  • 7Oldenmenger W H,Lieverse P J,Janssen P J,et al.Efficacy of opioid rotation to continuous parenteral hydromorphone in advanced cancer patients failing on other opioids[J].Support Care Cancer,2012,20(8):1639.
  • 8Chang A K,Bijur P E,Lupow J B,et al.Randomized clinical trial of the 2 mg hydromorphone bolus protocol versus the“1+1”hydromorphone titration protocol in treatment of acute,severe pain in the first hour of emergency department presentation[J].Ann Emerg Med,2013,62(4):304.

二级参考文献29

  • 1Mugabure Bujedo B. A clinical approach to neura:dal morphine for the treatment of postoperative pain[J]. Pain Res Treat,2012,2012:612-645.
  • 2Vora KS, Shah VR, Patel B, et al. Postoperative analgesia with epi- dural opioids after cesarean section : Comparison of sufentanil, mor- phine and sufentanil-morphine comblnation[J]. J Anaesthesiol Clin Pharmacol, 2012, 28 (4) :491-495.
  • 3Kumarasamy S, Choy YC. Epidural morphine for postoperative anal- gesia after caesarean section [ J ]. Acute Pain, 2008,10 : 117-121.
  • 4Bilir A. Single dose epidural morphine instead of patient-controlled epidural analgesia in the second day of cesarean section; an easy method for the pain relief of a new mother[ J]. Clin Exp Obstet Gy- necol, 2013, 40(1) :118-121.
  • 5Sultan P, Gutierrez MC, Carvalho B. Neuraxial morphine and re- spiratory depreesion : finding the right balance [ J ]. Drugs, 2011,71 (14) :1807-1819.
  • 6Horlocker TT, Burton AW, Connis RT, et al. Practice guideline for the prevention, detection, and management of respiratory depreesion associated with neuraxial opioid administratiom[ J]. Anesthesiology, 2009, 110(2) :218-230.
  • 7Kumar P, Sunkaraneni S, Sirohi S, et al. Hydromorphone efficacyand treatment protocol impact on tolerance and mu-opioid receptorregulation. Eur J Pharmacol, 2008, 597(1-3):39-45.
  • 8Felden L, Walter C, Harder S, et al. Comparative clinical effectsof hydromorphone and morphine: a meta-analysis. Br J Anaesth, 2011, 107(3):319-328.
  • 9Lussier D, Richarz U, Finco G. Use of hydromorphone, withparticular reference to the OROS formulation, in the elderly. Drugs aging,2010, 27(4):327-335.
  • 10Davison SN, Mayo PR. Pain management in chronic kidneydisease: the pharmacokinetics and pharmacodynamics of hydromorphoneand hydromorphone-3-glucuronide in hemodialysis patients. J OpioidManag, 2008, 4(6):335-336, 339-344.

共引文献88

同被引文献62

引证文献9

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部